Bioextrax: Which would you like to hear first? - VH Corp
Detta är en aktieanalys producerad av tredje part och reflekterar därför nödvändigtvis ej våra åsikter och värderingar
* Production increase from 100 to 300 tons of PHA per year from Konspec
* Project with the chemical company delayed, exclusivity removed
* We keep our fair value of SEK 4.23 per share
Good news and bad news caused some turbulence in the share price of Bioextrax
recently. The good news is that Konkan Specialty Products is planning to
produce more PHA than previously thought. The bad news is that the commercial
agreement with one of the world’s three largest chemical companies is being
delayed.
* Project with the chemical company delayed, exclusivity removed
* We keep our fair value of SEK 4.23 per share
Good news and bad news caused some turbulence in the share price of Bioextrax
recently. The good news is that Konkan Specialty Products is planning to
produce more PHA than previously thought. The bad news is that the commercial
agreement with one of the world’s three largest chemical companies is being
delayed.